About LivaNova Plc 
LivaNova Plc
Pharmaceuticals & Biotechnology
LivaNova PLC is a medical device company focused on the development and delivery of therapeutic solutions. The Company's segments include Cardiac Surgery and Neuromodulation. The Cardiac Surgery segment is engaged in the development, production and sale of cardiovascular surgery products. Cardiac Surgery products include oxygenators, heart-lung machines, autotransfusion, mechanical heart valves and tissue heart valves. The Neuromodulation segment is engaged in the design, development and marketing of neuromodulation therapy for the treatment of drug-resistant epilepsy and treatment resistant depression.
Company Coordinates 
Company Details
20 Eastbourne Terrace , LONDON None : W2 6LG
Registrar Details
Shareholding Snapshot
Shareholding Compare (%holding) 
Majority shareholders
Domestic Funds
Domestic Funds
Held in 74 Schemes (45.8%)
Foreign Institutions
Held by 125 Foreign Institutions (15.31%)
Strategic Entities with highest holding
Highest Public shareholder
Management
Designation
Mr. Daniel Moore
Independent Chairman of the Board
Mr. Damien McDonald
Chief Executive Officer, Director
Mr. Todd Schermerhorn
Director
Mr. Francesco Bianchi
Independent Director
Mr. William Kozy
Independent Director
Mr. Alfred Novak
Independent Director
Dr. Sharon O'Kane
Independent Director
Revenue and Profits:
Net Sales:
353 Million
(Quarterly Results - Jun 2025)
Net Profit:
27 Million
Pharmaceuticals & Biotechnology
USD 3,214 Million (Small Cap)
NA (Loss Making)
NA
0.00%
-0.14
-23.82%
2.86






